Economic impact of epilepsy in the United States

Purpose:  To assess differences in medical care expenditures and informal care received for adults and children by individuals’ self‐reported epilepsy status and to estimate the total economic impact of epilepsy in the United States.

[1]  Payer Costs of Patients Diagnosed with Epilepsy , 1999, Epilepsia.

[2]  S. Evers,et al.  Estimating the Costs of Epilepsy: An International Comparison of Epilepsy Cost Studies , 2001, Epilepsia.

[3]  Emily W. Gower,et al.  Economic impact of visual impairment and blindness in the United States. , 2007, Archives of ophthalmology.

[4]  D. Thurman,et al.  How common are the “common” neurologic disorders? , 2007, Neurology.

[5]  J. Annegers,et al.  Estimating the Cost of Epilepsy , 1999, Epilepsia.

[6]  M. Halpern,et al.  Economics in Epilepsy Treatment Choices: Our Certain Fate? , 2002, Epilepsia.

[7]  Ann Von Worley,et al.  Developing a computer algorithm to identify epilepsy cases in managed care organizations. , 2005, Disease management : DM.

[8]  L. Nichols,et al.  Variation in cost of informal caregiving and formal-service use for people with Alzheimer's desease , 2004, American journal of Alzheimer's disease and other dementias.

[9]  Comparing the cost of epilepsy across eight European countries , 2001, Epilepsy Research.

[10]  Samuel Wiebe,et al.  Epilepsy in North America: A Report Prepared under the Auspices of the Global Campaign against Epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization , 2006, Epilepsia.

[11]  B. Vengamma,et al.  Economic Burden of Epilepsy in India , 2001, Epilepsia.

[12]  F. Vale,et al.  Trends in the use of vagus nerve stimulation for epilepsy: analysis of a nationwide database. , 2008, Neurosurgical focus.

[13]  Ettore Beghi,et al.  The Economic Cost of Epilepsy: A Review of the Literature , 2002, Epilepsia.

[14]  E. So,et al.  The Cost of Epilepsy in the United States: An Estimate from Population‐Based Clinical and Survey Data , 2000, Epilepsia.

[15]  M. Bialer.  Generic Products of Antiepileptic Drugs (AEDs): Is It an Issue? , 2007, Epilepsia.

[16]  Stephen B. Cohen.  The Medical Expenditure Panel Survey: an overview. , 2002, Effective clinical practice : ECP.

[17]  R. Beran.  The Burden of Epilepsy for the Patient: The Intangible Costs , 1999, Epilepsia.

[18]  Chapin White,et al.  Health care spending growth: how different is the United States from the rest of the OECD? , 2007, Health affairs.

[19]  R. Fisher,et al.  The impact of epilepsy from the patient’s perspective II: views about therapy and health care , 2000, Epilepsy Research.

[20]  D R Lairson,et al.  Cost of Epilepsy in the United States: A Model Based on Incidence and Prognosis , 1994, Epilepsia.

[21]  Christoph Pachlatko.  The Relevance of Health Economics to Epilepsy Care , 1999, Epilepsia.

[22]  J. Mullahy.  Much Ado About Two: Reconsidering Retransformation and the Two-Part Model in Health Economics , 1998, Journal of health economics.

[23]  M. Druet‐Cabanac,et al.  Economic Evaluation of Epilepsy in Kiremba (Burundi): A Case–Control Study , 2004, Epilepsia.

[24]  R. Beran.  Economic Analysis of Epilepsy Care , 1999, Epilepsia.

[25]  E. Beghi,et al.  Cost of Epilepsy: Contrast of Methodologies in United States and European Studies , 1999, Epilepsia.

[26]  E. Perucca,et al.  Development of new antiepileptic drugs: challenges, incentives, and recent advances , 2007, The Lancet Neurology.